{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T14:37:26Z","timestamp":1770907046429,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T00:00:00Z","timestamp":1634083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T00:00:00Z","timestamp":1634083200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004410","name":"t\u00fcrkiye bilimsel ve teknolojik ara\u015ftirma kurumu","doi-asserted-by":"publisher","award":["315S039"],"award-info":[{"award-number":["315S039"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s11033-021-06786-z","type":"journal-article","created":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T21:48:45Z","timestamp":1634161725000},"page":"7755-7765","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Dual Akt and Bcl-2 inhibition induces cell-type specific modulation of apoptotic and autophagic signaling in castration resistant prostate cancer cell lines"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0132-3234","authenticated-orcid":false,"given":"Ezgi","family":"Avsar Abdik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3756-0645","authenticated-orcid":false,"given":"H\u00fcseyin","family":"Abdik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7775-2241","authenticated-orcid":false,"given":"Duygu","family":"Turan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7208-8967","authenticated-orcid":false,"given":"Fikrettin","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3783-5365","authenticated-orcid":false,"given":"Martin R.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1454-9374","authenticated-orcid":false,"given":"Ferda","family":"Kaleagasioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,13]]},"reference":[{"key":"6786_CR1","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s11912-018-0707-9","volume":"20","author":"K Arora","year":"2018","unstructured":"Arora K, Barbieri CE (2018) Molecular subtypes of prostate cancer. Curr Oncol Rep 20:58","journal-title":"Curr Oncol Rep"},{"key":"6786_CR2","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3389\/fphar.2017.00557","volume":"8","author":"P Wolf","year":"2017","unstructured":"Wolf P (2017) BH3 mimetics for the treatment of prostate cancer. Front Pharmacol 8:557","journal-title":"Front Pharmacol"},{"key":"6786_CR3","first-page":"6063","volume":"15","author":"Y Huang","year":"2018","unstructured":"Huang Y, Jiang X, Liang X, Jiang G (2018) Molecular and cellular mechanisms of castration resistant prostate cancer. Oncol Lett 15:6063\u20136076","journal-title":"Oncol Lett"},{"key":"6786_CR4","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nrm2239","volume":"8","author":"MC Maiuri","year":"2007","unstructured":"Maiuri MC, Zalckvar E, Kimchi A, Kroemer G (2007) Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol 8:741","journal-title":"Nat Rev Mol Cell Biol"},{"key":"6786_CR5","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3389\/fphar.2020.00547","volume":"11","author":"F Kalea\u011fas\u0131o\u011flu","year":"2020","unstructured":"Kalea\u011fas\u0131o\u011flu F, Ali DM, Berger MR (2020) Multiple facets of autophagy and the emerging role of alkylphosphocholines as autophagy modulators. Front Pharmacol 11:547","journal-title":"Front Pharmacol"},{"key":"6786_CR6","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/cdd.2010.191","volume":"18","author":"R Kang","year":"2011","unstructured":"Kang R, Zeh H, Lotze M, Tang D (2011) The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ 18:571\u2013580","journal-title":"Cell Death Differ"},{"key":"6786_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/1212369","volume":"2019","author":"Z Han","year":"2019","unstructured":"Han Z, Liang J, Li Y, He J (2019) Drugs and clinical approaches targeting the antiapoptotic protein: a review. BioMed Res Int 2019:1\u20136","journal-title":"BioMed Res Int"},{"key":"6786_CR8","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12935-015-0254-5","volume":"15","author":"A Talaiezadeh","year":"2015","unstructured":"Talaiezadeh A, Galehdari H, Khodadadi A (2015) Time depended Bcl-2 inhibition might be useful for a targeted drug therapy. Cancer Cell Int 15:105","journal-title":"Cancer Cell Int"},{"key":"6786_CR9","doi-asserted-by":"publisher","first-page":"256","DOI":"10.4161\/auto.6.2.11124","volume":"6","author":"S Huang","year":"2010","unstructured":"Huang S, Sinicrope F (2010) Celecoxib-induced apoptosis is enhanced by ABT-737 and by inhibition of autophagy in human colorectal cancer cells. Autophagy 6:256\u2013269","journal-title":"Autophagy"},{"key":"6786_CR10","doi-asserted-by":"publisher","first-page":"56698","DOI":"10.18632\/oncotarget.18082","volume":"8","author":"DE Butler","year":"2017","unstructured":"Butler DE, Marlein C, Walker HF, Frame FM, Mann VM, Simms MS et al (2017) Inhibition of the PI3K\/AKT\/mTOR pathway activates autophagy and compensatory Ras\/Raf\/MEK\/ERK signalling in prostate cancer. Oncotarget 8:56698","journal-title":"Oncotarget"},{"key":"6786_CR11","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41419-018-0342-2","volume":"9","author":"SS Ansari","year":"2018","unstructured":"Ansari SS, Sharma AK, Soni H, Ali DM, Tews B, K\u00f6nig R et al (2018) Induction of ER and mitochondrial stress by the alkylphosphocholine erufosine in oral squamous cell carcinoma cells. Cell Death Dis 9:296","journal-title":"Cell Death Dis"},{"key":"6786_CR12","first-page":"4463","volume":"15","author":"C Han","year":"2018","unstructured":"Han C, Xing G, Zhang M, Zhong M, Han Z, He C et al (2018) Wogonoside inhibits cell growth and induces mitochondrial-mediated autophagy-related apoptosis in human colon cancer cells through the PI3K\/AKT\/mTOR\/p70S6K signaling pathway. Oncol Lett 15:4463\u20134470","journal-title":"Oncol Lett"},{"key":"6786_CR13","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/CAD.0000000000000736","volume":"30","author":"E Avsar Abdik","year":"2019","unstructured":"Avsar Abdik E, Kaleagasioglu F, Abdik H, Sahin F, Berger MR (2019) ABT-737 and erufosine combination against castration-resistant prostate cancer: a promising but cell-type specific response associated with the modulation of anti-apoptotic signaling. Anticancer Drugs 30:383\u2013393","journal-title":"Anticancer Drugs"},{"key":"6786_CR14","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1002\/pros.20483","volume":"66","author":"IV Litvinov","year":"2006","unstructured":"Litvinov IV, Antony L, Dalrymple SL, Becker R, Cheng L, Isaacs JT (2006) PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor. Prostate 66:1329\u20131338","journal-title":"Prostate"},{"key":"6786_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-019-0089-y","volume":"5","author":"L Yang","year":"2020","unstructured":"Yang L, Shi P, Zhao G, Xu J, Peng W, Zhang J et al (2020) Targeting cancer stem cell pathways for cancer therapy. Signal Transduct Target Ther 5:1\u201335","journal-title":"Signal Transduct Target Ther"},{"key":"6786_CR16","first-page":"3429","volume":"60","author":"AY Liu","year":"2000","unstructured":"Liu AY (2000) Differential expression of cell surface molecules in prostate cancer cells. Can Res 60:3429\u20133434","journal-title":"Can Res"},{"key":"6786_CR17","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.21873\/invivo.12408","volume":"35","author":"C-Y Su","year":"2021","unstructured":"Su C-Y, Huang G-C, Chang Y-C, Chen Y-J, Fang H-W (2021) Analyzing the expression of biomarkers in prostate cancer cell lines. In vivo 35:1545\u20131548","journal-title":"In vivo"},{"key":"6786_CR18","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1073\/pnas.0810956106","volume":"106","author":"A Dubrovska","year":"2009","unstructured":"Dubrovska A, Kim S, Salamone RJ, Walker JR, Maira S-M, Garc\u00eda-Echeverr\u00eda C et al (2009) The role of PTEN\/Akt\/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations. Proc Natl Acad Sci 106:268\u2013273","journal-title":"Proc Natl Acad Sci"},{"key":"6786_CR19","doi-asserted-by":"publisher","first-page":"240","DOI":"10.4174\/astr.2018.95.5.240","volume":"95","author":"E Hwang","year":"2018","unstructured":"Hwang E, Hwang S-H, Kim J, Park JH, Oh S, Kim YA et al (2018) ABT-737 ameliorates docetaxel resistance in triple negative breast cancer cell line. Ann Surg Treatment Res 95:240\u2013248","journal-title":"Ann Surg Treatment Res"},{"key":"6786_CR20","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.tiv.2017.03.013","volume":"42","author":"M Opydo-Chanek","year":"2017","unstructured":"Opydo-Chanek M, Rak A, Cierniak A, Mazur L (2017) Combination of ABT-737 and resveratrol enhances DNA damage and apoptosis in human T-cell acute lymphoblastic leukemia MOLT-4 cells. Toxicol Vitro 42:38\u201346","journal-title":"Toxicol Vitro"},{"key":"6786_CR21","first-page":"4328","volume":"18","author":"HP Shen","year":"2019","unstructured":"Shen HP, Wu WJ, Ko JL, Wu TF, Yang SF, Wu CH et al (2019) Effects of ABT-737 combined with irradiation treatment on uterine cervical cancer cells. Oncol Lett 18:4328\u20134336","journal-title":"Oncol Lett"},{"key":"6786_CR22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s13402-016-0302-8","volume":"40","author":"SS Ansari","year":"2017","unstructured":"Ansari SS, Akg\u00fcn N, Berger MR (2017) Erufosine increases RhoB expression in oral squamous carcinoma cells independent of its tumor suppressive mode of action-a short report. Cell Oncol 40:89\u201396","journal-title":"Cell Oncol"},{"key":"6786_CR23","doi-asserted-by":"publisher","first-page":"5797","DOI":"10.18632\/oncotarget.23537","volume":"9","author":"SS Ansari","year":"2018","unstructured":"Ansari SS, Sharma AK, Zepp M, Ivanova E, Bergmann F, K\u00f6nig R et al (2018) Upregulation of cell cycle genes in head and neck cancer patients may be antagonized by erufosine\u2019s down regulation of cell cycle processes in OSCC cells. Oncotarget 9:5797","journal-title":"Oncotarget"},{"issue":"13","key":"6786_CR24","doi-asserted-by":"publisher","first-page":"4307","DOI":"10.1158\/1538-7445.AM2018-4307","volume":"78","author":"A Pervaiz","year":"2018","unstructured":"Pervaiz A, Akhtar MS, Mahmood S, Sajjad O, Khaliq S, Berger MR (2018) Molecular basis of cell cycle arrest induced by erufosine in metastatic breast cancer cells. AACR Cancer Res 78(13):4307","journal-title":"AACR Cancer Res"},{"key":"6786_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-016-0303-8","volume":"16","author":"M Broecker-Preuss","year":"2016","unstructured":"Broecker-Preuss M, Becher-Boveleth N, M\u00fcller S, Mann K (2016) The BH3 mimetic drug ABT-737 induces apoptosis and acts synergistically with chemotherapeutic drugs in thyroid carcinoma cells. Cancer Cell Int 16:1\u201312","journal-title":"Cancer Cell Int"},{"key":"6786_CR26","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.3892\/or.2017.5909","volume":"38","author":"F Zhang","year":"2017","unstructured":"Zhang F, Yu X, Liu X, Zhou T, Nie T, Cheng M et al (2017) ABT-737 potentiates cisplatin-induced apoptosis in human osteosarcoma cells via the mitochondrial apoptotic pathway. Oncol Rep 38:2301\u20132308","journal-title":"Oncol Rep"},{"key":"6786_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.archoralbio.2016.08.034","volume":"73","author":"L-H Kim","year":"2017","unstructured":"Kim L-H, Shin J-A, Jang B, Yang I-H, Won D-H, Jeong JH et al (2017) Sorafenib potentiates ABT-737-induced apoptosis in human oral cancer cells. Arch Oral Biol 73:1\u20136","journal-title":"Arch Oral Biol"},{"key":"6786_CR28","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3390\/cancers12010108","volume":"12","author":"I-L Hsin","year":"2020","unstructured":"Hsin I-L, Chou Y-H, Hung W-L, Ko J-L, Wang P-H (2020) The application of arsenic trioxide in ameliorating ABT-737 target therapy on uterine cervical cancer cells through unique pathways in cell death. Cancers 12:108","journal-title":"Cancers"},{"key":"6786_CR29","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.bbrc.2018.05.142","volume":"502","author":"Y-C Ou","year":"2018","unstructured":"Ou Y-C, Li J-R, Wang J-D, Chen W-Y, Kuan Y-H, Yang C-P et al (2018) Aspirin restores ABT-737-mediated apoptosis in human renal carcinoma cells. Biochem Biophys Res Commun 502:187\u2013193","journal-title":"Biochem Biophys Res Commun"},{"key":"6786_CR30","first-page":"161","volume":"50","author":"J Hao","year":"2012","unstructured":"Hao J, Mao X, Ding D, Du G, Liu Z (2012) The effect of cell killing by ABT-737 synergized with docetaxel in human prostate cancer PC-3 cells. Chin J Surg 50:161\u2013165","journal-title":"Chin J Surg"},{"key":"6786_CR31","doi-asserted-by":"publisher","first-page":"144","DOI":"10.7717\/peerj.144","volume":"1","author":"R Parrondo","year":"2013","unstructured":"Parrondo R, de las Pozas A, Reiner T, Perez-Stable G (2013) ABT-737, a small molecule Bcl-2\/Bcl-xL antagonist, increases antimitotic-mediated apoptosis in human prostate cancer cells. PeerJ 1:144","journal-title":"PeerJ"},{"key":"6786_CR32","doi-asserted-by":"publisher","first-page":"11399","DOI":"10.18632\/oncotarget.2550","volume":"5","author":"H Tamaki","year":"2014","unstructured":"Tamaki H, Harashima N, Hiraki M, Arichi N, Nishimura N, Shiina H et al (2014) Bcl-2 family inhibition sensitizes human prostate cancer cells to docetaxel and promotes unexpected apoptosis under caspase-9 inhibition. Oncotarget 5:11399","journal-title":"Oncotarget"},{"key":"6786_CR33","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1002\/pros.22487","volume":"72","author":"A Saleem","year":"2012","unstructured":"Saleem A, Dvorzhinski D, Santanam U, Mathew R, Bray K, Stein M et al (2012) Effect of dual inhibition of apoptosis and autophagy in prostate cancer. Prostate 72:1374\u20131381","journal-title":"Prostate"},{"key":"6786_CR34","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1002\/pros.21116","volume":"70","author":"B Pandit","year":"2010","unstructured":"Pandit B, Gartel AL (2010) New potential anti-cancer agents synergize with bortezomib and ABT-737 against prostate cancer. Prostate 70:825\u2013833","journal-title":"Prostate"},{"key":"6786_CR35","doi-asserted-by":"publisher","first-page":"66","DOI":"10.2174\/1871520618666181012093056","volume":"19","author":"F Kalea\u011fas\u0131o\u011flu","year":"2019","unstructured":"Kalea\u011fas\u0131o\u011flu F, Zaharieva MM, Konstantinov SM, Berger MR (2019) Alkylphospholipids are signal transduction modulators with potential for anticancer therapy. Anti-Cancer Agents Med Chem (Formerly Current Medicinal Chemistry-Anti-Cancer Agents) 19:66\u201391","journal-title":"Anti-Cancer Agents Med Chem (Formerly Current Medicinal Chemistry-Anti-Cancer Agents)"},{"key":"6786_CR36","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00280-007-0612-7","volume":"62","author":"M Fiegl","year":"2008","unstructured":"Fiegl M, Lindner LH, Juergens M, Eibl H, Hiddemann W, Braess J (2008) Erufosine, a novel alkylphosphocholine, in acute myeloid leukemia: single activity and combination with other antileukemic drugs. Cancer Chemother Pharmacol 62:321\u2013329","journal-title":"Cancer Chemother Pharmacol"},{"key":"6786_CR37","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/leu.2010.32","volume":"24","author":"A Martelli","year":"2010","unstructured":"Martelli A, Papa V, Tazzari P, Ricci F, Evangelisti C, Chiarini F et al (2010) Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK-and PP2A-dependent mechanisms. Leukemia 24:687\u2013698","journal-title":"Leukemia"},{"key":"6786_CR38","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.leukres.2009.12.003","volume":"34","author":"SK K\u00f6nigs","year":"2010","unstructured":"K\u00f6nigs SK, Pallasch CP, Lindner LH, Schwamb J, Schulz A, Brinker R et al (2010) Erufosine, a novel alkylphosphocholine, induces apoptosis in CLL through a caspase-dependent pathway. Leuk Res 34:1064\u20131069","journal-title":"Leuk Res"},{"key":"6786_CR39","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1196\/annals.1397.022","volume":"1095","author":"M Zaharieva","year":"2007","unstructured":"Zaharieva M, Konstantinov S, Pilicheva B, Karaivanova M, Berger M (2007) Erufosine: a membrane targeting antineoplastic agent with signal transduction modulating effects. Ann N Y Acad Sci 1095:182\u2013192","journal-title":"Ann N Y Acad Sci"},{"key":"6786_CR40","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00280-010-1273-5","volume":"67","author":"DY Yosifov","year":"2011","unstructured":"Yosifov DY, Todorov PT, Zaharieva MM, Georgiev KD, Pilicheva BA, Konstantinov SM et al (2011) Erucylphospho-N, N, N-trimethylpropylammonium (erufosine) is a potential antimyeloma drug devoid of myelotoxicity. Cancer Chemother Pharmacol 67:13\u201325","journal-title":"Cancer Chemother Pharmacol"},{"key":"6786_CR41","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.leukres.2013.10.011","volume":"38","author":"DY Yosifov","year":"2014","unstructured":"Yosifov DY, Kaloyanov KA, Guenova ML, Prisadashka K, Balabanova MB, Berger MR et al (2014) Alkylphosphocholines and curcumin induce programmed cell death in cutaneous T-cell lymphoma cell lines. Leuk Res 38:49\u201356","journal-title":"Leuk Res"},{"key":"6786_CR42","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/1748-717X-7-172","volume":"7","author":"G Henke","year":"2012","unstructured":"Henke G, Meier V, Lindner LH, Eibl H, Bamberg M, Belka C et al (2012) Effects of ionizing radiation in combination with Erufosine on T98G glioblastoma xenograft tumours: a study in NMRI nu\/nu mice. Radiat Oncol 7:172","journal-title":"Radiat Oncol"},{"key":"6786_CR43","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s10495-010-0460-5","volume":"15","author":"L Veenman","year":"2010","unstructured":"Veenman L, Alten J, Linnemannst\u00f6ns K, Shandalov Y, Zeno S, Lakomek M et al (2010) Potential involvement of F 0 F 1-ATP (synth) ase and reactive oxygen species in apoptosis induction by the antineoplastic agent erucylphosphohomocholine in glioblastoma cell lines. Apoptosis 15:753\u2013768","journal-title":"Apoptosis"},{"key":"6786_CR44","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.canlet.2011.12.032","volume":"319","author":"V Kapoor","year":"2012","unstructured":"Kapoor V, Zaharieva MM, Das SN, Berger MR (2012) Erufosine simultaneously induces apoptosis and autophagy by modulating the Akt\u2013mTOR signaling pathway in oral squamous cell carcinoma. Cancer Lett 319:39\u201348","journal-title":"Cancer Lett"},{"key":"6786_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41420-019-0206-2","volume":"5","author":"DM Ali","year":"2019","unstructured":"Ali DM, Ansari SS, Zepp M, Knapp-Mohammady M, Berger MR (2019) Optineurin downregulation induces endoplasmic reticulum stress, chaperone-mediated autophagy, and apoptosis in pancreatic cancer cells. Cell Death Discov 5:1\u201315","journal-title":"Cell Death Discov"},{"key":"6786_CR46","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/1748-717X-5-108","volume":"5","author":"J Rudner","year":"2010","unstructured":"Rudner J, Ruiner C-E, Handrick R, Eibl H-J, Belka C, Jendrossek V (2010) The Akt-inhibitor Erufosine induces apoptotic cell death in prostate cancer cells and increases the short term effects of ionizing radiation. Radiat Oncol 5:108","journal-title":"Radiat Oncol"},{"key":"6786_CR47","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.3892\/or.2013.2942","volume":"31","author":"F Kalea\u011fas\u0131o\u011flu","year":"2014","unstructured":"Kalea\u011fas\u0131o\u011flu F, Berger MR (2014) Differential effects of erufosine on proliferation, wound healing and apoptosis in colorectal cancer cell lines. Oncol Rep 31:1407\u20131416","journal-title":"Oncol Rep"},{"key":"6786_CR48","doi-asserted-by":"publisher","first-page":"20","DOI":"10.4103\/1477-3163.83937","volume":"10","author":"PE Lonergan","year":"2011","unstructured":"Lonergan PE, Tindall DJ (2011) Androgen receptor signaling in prostate cancer development and progression. J Carcinog 10:20","journal-title":"J Carcinog"},{"key":"6786_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-78798-x","volume":"10","author":"R Smith","year":"2020","unstructured":"Smith R, Liu M, Liby T, Bayani N, Bucher E, Chiotti K et al (2020) Enzalutamide response in a panel of prostate cancer cell lines reveals a role for glucocorticoid receptor in enzalutamide resistant disease. Sci Rep 10:1\u201313","journal-title":"Sci Rep"},{"key":"6786_CR50","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1080\/15548627.2015.1017191","volume":"11","author":"JMB-S Pedro","year":"2015","unstructured":"Pedro JMB-S, Wei Y, Sica V, Maiuri MC, Zou Z, Kroemer G et al (2015) BAX and BAK1 are dispensable for ABT-737-induced dissociation of the BCL2-BECN1 complex and autophagy. Autophagy 11:452\u2013459","journal-title":"Autophagy"},{"key":"6786_CR51","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/aps.2011.192","volume":"33","author":"Y Tong","year":"2012","unstructured":"Tong Y, You L, Qian W (2012) Perifosine induces protective autophagy and upregulation of ATG5 in human chronic myelogenous leukemia cells in vitro. Acta Pharmacol Sin 33:542\u2013550","journal-title":"Acta Pharmacol Sin"},{"key":"6786_CR52","doi-asserted-by":"publisher","first-page":"332","DOI":"10.3390\/ijms17030332","volume":"17","author":"M Li","year":"2016","unstructured":"Li M, Gao P, Zhang J (2016) Crosstalk between autophagy and apoptosis: potential and emerging therapeutic targets for cardiac diseases. Int J Mol Sci 17:332","journal-title":"Int J Mol Sci"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06786-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-021-06786-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06786-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T14:26:23Z","timestamp":1675779983000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-021-06786-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,13]]},"references-count":52,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["6786"],"URL":"https:\/\/doi.org\/10.1007\/s11033-021-06786-z","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,13]]},"assertion":[{"value":"6 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study does not require ethical statement.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}